Interest of Thromboelastography (ROTEM) as a Biomarker of Revascularisation in Stroke "ROTEMPredict"


Phase N/A Results N/A

Summary of Purpose

Revascularisation using recombinant tPA is the reference treatment of stroke. However, the efficacy of fibrinolysis is about 50%. Several factors, including the size of thrombus, have been associated with revascularisation efficacy. The aim of this prospective study is to evaluate ex vivo the effect of tPA in patients with stroke with thromboelastography and to correlate results with the clinical outcome of ...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 September 2016.

1 Jul 2016 7 Sep 2016 1 Jun 2018 1 Sep 2018 1 Sep 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Observation: Case-Only
  • Perspective: Prospective
  • Sampling: Probability Sample